返回 
加入收藏
我国31省（区、市）低价药品清单遴选情况分析
x
请在关注微信后，向客服人员索取文件
| 篇名： | 我国31省（区、市）低价药品清单遴选情况分析 |
| TITLE： | |
| 摘要： | 目的：为各省、自治区、直辖市[以下简称省（区、市）]动态调整低价药品清单、更好地保障低价药品供应提供参考。方法：统计国家和31省（区、市）低价药品清单的品种数和频数等，对省（区、市）级低价药品清单遴选的影响因素进行分析。结果：国家低价药品清单共包含533个品种，其中西药283个品种，中成药250个品种，60个为独家品种。31省（区、市）共遴选973种通用名药品，其中西药332种，中成药630种，民族药11种，71个为中药保护品种。西部与东部遴选的药品品种数差异不大，中部较少；广西省遴选药品品种数最多，为345种，江西省最少，仅为10种；各省（区、市）遴选的中成药品种数均高于西药，同时中成药的集中度较西药高。出现频次最高的西药为酮替芬，中成药为通便灵胶囊，分别有30和29省（区、市）将其列入低价药品清单。各省（区、市）低价药品清单与其基本药物增补目录重合率均不高，遴选的低价药品种数与本省（区、市）药品生产企业数呈中度相关性。结论：应加快形成多省（区、市）间的低价药品联动政策，同时注重与国家基本药物制度的衔接，从根本上保障患者的临床用药需求。 |
| ABSTRACT： | OBJECTIVE： To provide reference for dynamic adjustment of low-cost medicine lists and better guarantee of low-cost supply in those provinces，autonomous regions and municipalities[referred to provinces（autonomous regions or municipalities）]. METHODS： The varieties and frequency of medicines in the national and 31 province（autonomous regions or municipalities） lists were counted， and the influential factors were analyzed. RESULTS： The National Low-cost Medicine List included 533 varieties of medicines， including 283 western medicines， 250 Chinese patent medicines and 60 exclusive varieties. There were totally 973 varieties of medicines in the 31 province（autonomous regions or municipalities）， including 332 western medicines， 630 Chinese patent medicines， 11 ethnic medicines and 71 protected Chinese medicines. There was no big difference in the varieties between the eastern and western areas， and less in the central areas. Guangxi province had the largest number of selected medicines （345 varieties） and Jiangxi province had the smallest （10 varieties）. In all the varieties， Chinese medicines had a larger number than western medicines， and also better concentration. Ketotifen was the most frequent western medicine and Tongbianling capsule was the most frequent Chinese patent medicine， which appeared 30 and 29 times separately. The Provincial Low-cost Medicine Lists and the Essential Medicine Supplement Lists had a poor coincidence rate， and there was a moderate correlation between the varieties and the number of pharmaceutical manufacturers in the province（autonomous regions or municipalities）. CONCLUSIONS： The adjustment of low-cost medicine lists should be combined with these in province（autonomous regions or municipalities） nearby， and notice the linkage with national essential medicine system to fundamentally ensure the clinical medication requirements of patients. |
| 期刊： | 2015年第26卷第36期 |
| 作者： | 赵熙子，管晓东，崔岩，韩晟，陈敬，史录文 |
| AUTHORS： | ZHAO Xi-zi，GUAN Xiao-dong，CUI Yan，HAN Sheng，CHEN Jing，SHI Lu-wen |
| 关键字： | 低价药品清单；遴选；国家基本药物目录；省级基本药物增补目录 |
| KEYWORDS： | Low-cost medicine list； Select； National essential medicine list； Provincial essential medicine supplement list |
| 阅读数： | 491 次 |
| 本月下载数： | 4 次 |
* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！
